SCYNEXIS, Inc.

SCYXNASDAQHealthcare● Active

$4.45

$-0.26(-5.52%)

Market Cap$27984791

P/E Ratio—

52W High$10.48

52W Low$4.45

Avg Volume75K

Open$4.70

Beta1.04

Employees Ownership Insider Trades

SCYNEXIS, Inc. (SCYX) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · SCYX · as of Mar 4, 2026

Latest filing snapshot

-10-35.71%vs prior year

SCYNEXIS, Inc. (SCYX) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

Change (1Y)

-10

Growth % (1Y)

-35.71%

Revenue / Employee

$1.14M

Net Income / Employee

$-478.3K

Market Cap

$28M

SCYX Employee Count

2014 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-03-04	2025-12-31	18	-10	-35.71%
2025-03-12	2024-12-31	28	-1	-3.45%
2024-03-28	2023-12-31	29	-7	-19.44%
2023-03-31	2022-12-31	36	-20	-35.71%
2022-03-29	2021-12-31	56	+18	+47.37%
2021-03-29	2020-12-31	38	+11	+40.74%
2020-03-11	2019-12-31	27	+3	+12.50%
2019-03-14	2018-12-31	24	+5	+26.32%
2018-03-13	2017-12-31	19	+5	+35.71%
2017-03-13	2016-12-31	14	+3	+27.27%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Drug Manufacturers - Specialty & Generic

#SymbolCompanyEmployeesMkt Cap

CollPlant Biotechnologies Ltd.

NeuroSense Therapeutics Ltd.

17$19M #6

CVKD

Cadrenal Therapeutics, Inc. Common Stock

4$12M

KLTO

Klotho Neurosciences, Inc.

3$20M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · SCYX peer comparison

About SCYX employees

SCYX Employees · Headcount

SCYNEXIS, Inc. (SCYX) employee data is sourced from the annual SEC 10-K filing. As of 2025, SCYNEXIS, Inc. had 18 full-time employees globally. Full-time employees only. Global consolidated headcount.

SCYNEXIS, Inc. employs 18 full-time employees as of the latest filing within the Drug Manufacturers - Specialty & Generic industry. Revenue per employee stands at $1.14M, reflecting the company's operational efficiency.

SCYNEXIS, Inc.'s workforce decreased by 10 (35.71%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

SCYNEXIS, Inc.'s revenue per employee of $1.14M positions it among the notable performers in the Drug Manufacturers - Specialty & Generic sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

SCYX Employees · 5 questions

As of the latest SEC 10-K filing (2025), SCYNEXIS, Inc. had 18 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

SCYNEXIS, Inc. employee counthow many employees does SCYNEXIS, Inc. haveSCYX total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-04